Health system costs for stage-specific breast cancer: A population-based approach

Current Oncology

Volumn 21, Issue 6, 2014, Pages 281-293

  Mittmann, N ^a,b,c,d   Porter, J M ^e   Rangrej, J ^e   Seung, S J ^a   Liu, N ^e   Saskin, R ^e   Cheung, M C ^f   Leighl, N B ^g   Hoch, J S ^d,h   Trudeau, M ^f   Evans, W K ⁱ   Dainty, K N ^h   DeAngelis, C ^f   Earle, C C ^e,f  

^a SUNNYBROOK RESEARCH INSTITUTE   (Canada)

^b UNIVERSITY OF TORONTO   (Canada)

^c UNIVERSITY OF WESTERN ONTARIO   (Canada)

^d CANCER CARE ONTARIO   (Canada)

^e INSTITUTE FOR CLINICAL EVALUATIVE SCIENCES   (Canada)

^f DEPARTMENT OF RADIATION ONCOLOGY   (Canada)

^g PRINCESS MARGARET HOSPITAL   (Canada)

^h ST MICHAEL'S HOSPITAL   (Canada)

ⁱ MCMASTER UNIVERSITY   (Canada)

Author keywords

Breast cancer; Costs; Disease stage; Population based analysis

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER CHEMOTHERAPY; CANCER REGISTRY; CANCER STAGING; CONTROLLED STUDY; DRUG COST; FEMALE; HEALTH CARE COST; HEALTH SERVICE; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MEDICAL FEE; MIDDLE AGED; REHABILITATION CARE; RESOURCE MANAGEMENT; VERY ELDERLY;

EID: 84916203644     PISSN: None     EISSN: 17187729     Source Type: Journal    
DOI: 10.3747/co.21.2143     Document Type: Article

References (19)

1. The Conference Board of Canada (cboc). Home > How Canada Performs > International Rankings > Health > Mortality Due to Cancer [Web page]. Ottawa, ON: cboc; 2012. [Available at: http://www.conferenceboard.ca/hcp/details/health/mortalitycancer.aspx; cited February 26, 2012]
2. Canadian Cancer Society. Home > Cancer information > Cancer type > Breast > Statistics. Breast Cancer Statistics [Web page]. Toronto, ON: Canadian Cancer Society; 2014. [Available at: http://www.cancer.ca/en/cancer-information/cancer-type/breast/statistics/?region=mb; cited June 18, 2014]
3. Patra J, Popova S, Rehm J, Bondy S, Flint R, Giesbrecht N. Economic Cost of Chronic Disease in Canada 1995-2003. Toronto, ON: Ontario Chronic Disease Prevention Alliance; 2007. [Available online at: http://ocdpa.ca/sites/default/files/publications/OCDPA_EconomicCosts.pdf; cited January 15, 2014]
4. Will BP, Bertheolot JM, Le Petit C, Tomiak EM, Verma S, Evans WK. Estimates of the lifetime costs of breast cancer treatment in Canada. Eur J Cancer 2000;36:724-35.
5. de Oliveria C, Bremner KE, Pataky R, et al.Understanding the costs of cancer before and after diagnosis for the 21 most common cancers in Ontario: a population-based descriptive study. CMAJ Open 2013;1:E1-8.
6. de Oliveria C, Bremner KE, Pataky R, et al.Trends in use and cost of initial cancer treatment in Ontario: a population-based descriptive study. CMAJ Open 2013;1:E151-8.
7. Mittmann N, Liu N, Porter JM, et al.End-of-life home care utilization and costs in patients with advanced colorectal cancer. J Community Support Oncol 2014;12:92-8.
8. Mittmann N, Liu N, Porter J, et al.Utilization and costs of home care for patients with colorectal cancer: a populationbased study. CMAJ Open 2014;2:E11-17.
9. Mittmann N, Isogai PK, Saskin R, et al.Population-based home care services in breast cancer: utilization and costs. Curr Oncol 2012;19:e383-91.
10. Cancer Care Ontario (cco). Stage Data Resolution Interim Solution for User Access. Version 1.0. Toronto, ON: cco; 2011.
11. Campbell JD, Ramsey SD. The costs of treating breast cancer in the US—a synthesis of published evidence. Pharmacoeconomics 2009;27:199-209.
12. Breast cancer stage cost analysis in a managed care population. Based on a presentation by Kenneth L. McDonough, md, ms. Am J Manag Care 1999;5(suppl):S377-82.
13. Legorreta AP, Brooks RG, Leibowitz AN, Solin LJ. Cost of breast cancer treatment: a 4-year longitudinal study. Arch Intern Med 1996;156:2197-201.
14. Hassett MJ, O’Malley AJ, Pakes JR, Newhouse JP, Earle CC. Frequency and cost of chemotherapy-related serious adverse effects in a population sample of women with breast cancer. J Natl Cancer Inst 2006;98:1108-17.
15. Lamerato L, Havstad S, Gandhi S, Jones D, Nathanson D. Economic burden associated with breast cancer recurrence: findings from a retrospective analysis of health system data. Cancer 2006;106:1875-82.
16. Remák E, Brazil L. Cost of managing women presenting with stage iv breast cancer in United Kingdom. Br J Cancer 2004;91:77-83.
17. Lidgren M, Wilking N, Jõnsson B, Rehnberg C. Resource use and costs associated with different states of breast cancer. Int J Technol Assess Health Care 2007;23:223-31.
18. Broekx S, Den Hond E, Torfs R, et al.The costs of breast cancer prior to and following diagnosis. Eur J Health Econ 2011;12:311-17.
19. Gordon L, Scuffham P, Hayes S, Newman B. Exploring the economic impact of breast cancers during the 18 months following diagnosis. Pyschooncology 2007;16:1130-9.